James Dentzer - President & CEO, Curis Inc

As of January 29, 2021


James Dentzer Net Worth

  • Net worth is estimated to be at least $765.37K
  • Owns at least 67,268 units of Curis Inc stock
  • Sold an estimated value of $75.23K in the last 4 years at Curis Inc

James Dentzer Compensation at Curis Inc in 2020

  • Earned a $544,900 salary
  • Received a total compensation of $1,672,849

James Dentzer Trading

  • Largest sale of shares was 5,377 units , worth over $57.78K on January 26, 2021
  • In total has made about 10 transactions over 4 years
  • Usually trades in January, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

James Dentzer Mailing Address

  • Mailing address is C/o Amicus Therapeutics, Inc. 6 Cedar Brook Drive Cranbury NJ 08512 NJ

Curis Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
James E. Dentzer 2020 $544,900 - $627,075 $476,685 $14,189 $1,672,849
James E. Dentzer 2019 $509,507 - $849,513 $183,547 $15,206 $1,557,773
James E. Dentzer 2018 $479,383 $142,313 $1,031,405 $297,000 $14,635 $1,964,736
Robert E. Martell, M.D., Ph.D. 2020 $366,091 - $321,899 $261,954 $11,401 $961,345
Robert E. Martell, M.D., Ph.D. 2019 $342,245 - $294,620 $128,429 $11,200 $776,494
Robert E. Martell, M.D., Ph.D. 2018 $186,712 $127,650 $475,377 $124,688 $26,042 $940,469
William E. Steinkrauss 2020 $352,135 - $321,899 $201,960 $15,761 $891,755
William E. Steinkrauss 2019 $284,301 - $248,875 $91,501 $65,488 $690,165
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1108205/000119312521116336/d88919ddef14a.htm

Curis Inc Insider Trading

  • The most recent transaction was 5,377 units sold on January 26, 2021 by James Dentzer worth over $57.78K
  • In the last 18 years, insiders at Curis Inc sold an estimated value of $21.29M and bought an estimated value of $31.45M
  • The most active traders are James McNab, Director,  Daniel Passeri, Director,  and Martyn Greenacre, Director
  • Insider trading is most common in January, with the busiest year in 2004
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1